GQX-27145-06740
2 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 483 / MI
- Registered
- 2021-07-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-30
Registered in v-safe
-
2021-07-30
Dose 1 — Pfizer-BioNTech
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-13
-
2021-08-20
Dose 2 — Pfizer-BioNTech
- 2021-08-20
-
2021-08-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-27
-
2021-09-03
Survey response — day 14, dose 2MedDRA: Live birth — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Gave birth to a healthy babyMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-10
- 2021-09-17
- 2021-09-24
- 2021-10-03
- 2021-11-19
- 2022-02-18
- 2022-08-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Gave birth to a healthy baby
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Live birth | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release